INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 65 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $426,000 | +161.3% | 157,247 | +84.1% | 0.02% | +150.0% |
Q2 2018 | $163,000 | +3975.0% | 85,412 | +3458.8% | 0.01% | – |
Q2 2017 | $4,000 | -97.7% | 2,400 | -95.5% | 0.00% | -100.0% |
Q1 2017 | $173,000 | +133.8% | 53,700 | -1.5% | 0.02% | +88.9% |
Q4 2016 | $74,000 | +252.4% | 54,500 | +300.7% | 0.01% | +350.0% |
Q3 2016 | $21,000 | -12.5% | 13,600 | -25.7% | 0.00% | -33.3% |
Q2 2016 | $24,000 | +100.0% | 18,300 | +698.1% | 0.00% | +50.0% |
Q1 2016 | $12,000 | -70.0% | 2,293 | -55.2% | 0.00% | -66.7% |
Q4 2015 | $40,000 | -46.7% | 5,123 | -25.8% | 0.01% | -40.0% |
Q2 2015 | $75,000 | +66.7% | 6,900 | +115.6% | 0.01% | +66.7% |
Q1 2015 | $45,000 | -75.8% | 3,200 | -70.9% | 0.01% | -77.8% |
Q4 2014 | $186,000 | +675.0% | 11,000 | +450.0% | 0.03% | +800.0% |
Q1 2014 | $24,000 | +242.9% | 2,000 | +300.0% | 0.00% | +200.0% |
Q4 2013 | $7,000 | -58.8% | 500 | -50.0% | 0.00% | -66.7% |
Q3 2013 | $17,000 | -89.6% | 1,000 | -90.0% | 0.00% | -91.4% |
Q2 2013 | $163,000 | -95.2% | 10,048 | -85.8% | 0.04% | -94.5% |
Q1 2013 | $3,419,000 | – | 70,548 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $819,180 | 0.18% |
BVF INC/IL | 6,353,645 | $3,526,273 | 0.15% |
Gratus Capital, LLC | 1,323,598 | $734,600 | 0.06% |
Bleichroeder LP | 250,000 | $138,750 | 0.03% |
PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $302,757 | 0.01% |
Callan Capital, LLC | 158,500 | $87,968 | 0.01% |
Polar Capital Holdings Plc | 2,071,242 | $1,149,539 | 0.01% |
Virtu Financial LLC | 66,537 | $37 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $138,195 | 0.00% |
Pacific Sage Partners, LLC | 17,500 | $9,713 | 0.00% |